StockDuty ← Dashboard Sep 25, 2026 04:15 AM ET
SignalFDA/Bio

J&J and Contineum’s Depression Drug Missed Phase 2 Goal. What Comes Next?

J&J and Contineum’s depression drug missed Phase 2 goal, prompting next-steps uncertainty.

What changed
J&J and Contineum’s depression drug missed Phase 2 goal, prompting next-steps uncertainty.
Why it matters
J&J and Contineum’s depression drug missed Phase 2 goal, prompting next-steps uncertainty. — impact context not separately stored; see What changed.
Sources
eodhd
Related signals
PHASE 1 OF INDIA - US TRADE PACT HINGES ON SECTION 301 PROBE , OFFICIAL SAYS →PITNEY BOWES OUTLINES PHASE 2 STRATEGIC REVIEW WHILE PUSHING NEAREST DEBT MATURITY TO MARCH 2029 - SEEKINGALPHA →UNICYCIVE PLUMMETS FOLLOWING SECOND CRL FOR OLC FOR HYPERPHOSPHATEMIA - SEEKINGALPHA →